Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction

[1]  J. Irie,et al.  Telmisartan but Not Candesartan Affects Adiponectin Expression In Vivo and In Vitro , 2008, Hypertension Research.

[2]  M. Kontogianni,et al.  Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis , 2008, Clinical Rheumatology.

[3]  Yoshiya Tanaka,et al.  Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. , 2008, Endocrine journal.

[4]  G. Fantuzzi.  Adiponectin and inflammation: consensus and controversy. , 2008, The Journal of allergy and clinical immunology.

[5]  C. Allaart,et al.  A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[6]  R. Rau,et al.  Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. , 2007, Arthritis and rheumatism.

[7]  D. Coady,et al.  Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers. , 2007, Arthritis and rheumatism.

[8]  N. Komai,et al.  Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis , 2007, Modern rheumatology.

[9]  Libin Zhou,et al.  C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes. , 2007, The Journal of endocrinology.

[10]  H. Yamanaka,et al.  Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values , 2006, Annals of the rheumatic diseases.

[11]  K. Pavelka,et al.  Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. , 2006, Cytokine.

[12]  U. Müller-Ladner,et al.  The Potential of Adiponectin in Driving Arthritis1 , 2006, The Journal of Immunology.

[13]  Y. Nakaya,et al.  Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis. , 2006, The journal of medical investigation : JMI.

[14]  J. Gómez-Reino,et al.  Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[15]  H. Xie,et al.  Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. , 2005, Experimental cell research.

[16]  M. Matsuda,et al.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. , 2005, Biochemical and biophysical research communications.

[17]  H. Oonishi,et al.  Knee and/or hip joint destruction in rheumatoid arthritis is associated with HLA-DRB1*0405 in Japanese patients , 2005, Clinical Rheumatology.

[18]  S. Kihara,et al.  Adiponectin as a biomarker of the metabolic syndrome. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[19]  K. Ikari,et al.  Cartilage oligomeric matrix protein in serum and synovial fluid of rheumatoid arthritis: potential use as a marker for joint cartilage damage , 2004, Modern rheumatology.

[20]  M. Wulster-Radcliffe,et al.  Adiponectin differentially regulates cytokines in porcine macrophages. , 2004, Biochemical and biophysical research communications.

[21]  M. Matsuda,et al.  Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.

[22]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[23]  H. Hagino,et al.  Cross-Sectional and Longitudinal Study of Osteoporosis in Patients with Rheumatoid Arthritis , 2002, Clinical Rheumatology.

[24]  R. Paschke,et al.  Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. , 2002, Biochemical and biophysical research communications.

[25]  B. Dijkmans,et al.  Predictors of radiographic joint damage in patients with early rheumatoid arthritis , 2001, Annals of the rheumatic diseases.

[26]  L. Kiemeney,et al.  The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[27]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.

[28]  H. Kautiainen,et al.  Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study. , 2000, Rheumatology.

[29]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[30]  T. Ochi,et al.  Osteoclastogenesis in iliac bone marrow of patients with rheumatoid arthritis. , 1997, The Journal of rheumatology.

[31]  T. Ochi,et al.  The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. , 1997, British journal of rheumatology.

[32]  D. Furst,et al.  Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein. , 1994, The Journal of laboratory and clinical medicine.

[33]  J. Meer,et al.  Circulating soluble tumor necrosis factor receptors, interleukin‐2 receptors, tumor necrosis factor α, and interleukin‐6 levels in rheumatoid arthritis. , 1993 .

[34]  R. Sauerwein,et al.  Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. , 1993, Arthritis and rheumatism.

[35]  M. A. van 't Hof,et al.  Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[36]  D A Bloch,et al.  The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. , 1991, Arthritis and rheumatism.

[37]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[38]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[39]  Takako Sasaki,et al.  Serum Clq levels as a prognostic guide to articular erosions in patients with rheumatoid arthritis , 1984 .

[40]  T. Ochi,et al.  Serum C1q levels as a prognostic guide to articular erosions in patients with rheumatoid arthritis. , 1984, Arthritis and rheumatism.

[41]  O. Steinbrocker,et al.  Therapeutic criteria in rheumatoid arthritis. , 1949, Journal of the American Medical Association.